Erin Hodges is a Dermatology physician affiliated with Centers for Disease Control and Prevention. OpenAlex indexes 15 publications with 424 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
630 Matthews Township Pkwy
Matthews, NC 281055322
Telephone
704-495-6334Provider last certified this registry record 6 May 2026.
Industry payments
27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year202530 payments
- UCB, Inc.Program year20259 payments
- Lilly USA, LLCProgram year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
28%Corticosteroid18.1%Triamcinolone Acetonide85%Triamcinolone acetonide15%Part D + Part B≥85 patientsSulfonamide Antibacterial5.6%Silver Sulfadiazine50%Ssd50%Part D≥14 patients+ 2 more classes in this area
Anti-infectives
27.9%Azole Antifungal14.5%Ketoconazole100%Part D≥62 patientsTetracycline-class Drug7.8%Doxycycline Hyclate100%Part D≥20 patients+ 3 more classes in this area
Sensory organs
26.5%Corticosteroid26.5%Clobetasol Propionate54%Hydrocortisone36%Betamethasone Dipropionate10%Part D≥64 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Development of an RNA Strand-Specific Hybridization Assay To Differentiate Replicating versus Nonreplicating Influenza A Viruses
Journal of Clinical Microbiology
2020 - Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018
Scientific Reports
2019 - Avian Influenza A(H7N2) Virus in Human Exposed to Sick Cats, New York, USA, 2016
Emerging infectious diseases
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Alicia Fry
Centers for Disease Control and Prevention
Matthew D. Ritchey
Centers for Disease Control and Prevention
Marc Fischer
Centers for Disease Control and Prevention
Lorenzo Botto, MD
Centers for Disease Control and Prevention
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”